BiotechTube

Amniotic Suspension Allograft + Placebo

Phase 3Completed
0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Knee Osteoarthritis

Conditions

Knee Osteoarthritis

Trial Timeline

Dec 14, 2020 → Aug 19, 2025

NCT ID
NCT04636229

About Amniotic Suspension Allograft + Placebo

Amniotic Suspension Allograft + Placebo is a phase 3 stage product being developed by Organogenesis for Knee Osteoarthritis. The current trial status is completed. This product is registered under clinical trial identifier NCT04636229. Target conditions include Knee Osteoarthritis.

What happened to similar drugs?

8 of 20 similar drugs in Knee Osteoarthritis were approved

Approved (8) Terminated (0) Active (12)
✅NISEDr. Reddy's LaboratoriesApproved
✅Capsaicin Topical SolutionAstellas PharmaApproved
🔄Duloxetine + PlaceboShionogiPhase 3
🔄DuloxetineShionogiPhase 3
🔄Duloxetine + PlaceboEli LillyPhase 3
🔄Duloxetine (DLX) + Placebo (PLA)Eli LillyPhase 3
🔄Duloxetine + placeboEli LillyPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
5
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT06000410Phase 3Completed
NCT04636229Phase 3Completed

Competing Products

20 competing products in Knee Osteoarthritis

See all competitors
ProductCompanyStageHype Score
NISEDr. Reddy's LaboratoriesApproved
40
NISELATDr. Reddy's LaboratoriesPre-clinical
23
LY2828360 + PlaceboEli LillyPhase 2
35
UBX0101 or placeboUnity BiotechnologyPre-clinical
8
UBX0101Unity BiotechnologyPhase 1
19
UBX0101Unity BiotechnologyPhase 2
25
UBX0101Unity BiotechnologyPhase 1
19
YH23537 + Celecoxib + YH23537 placeboYuhanPhase 2
35
YM150 + WarfarinAstellas PharmaPhase 2
35
ASP7962 + Naproxen + PlaceboAstellas PharmaPhase 2
35
Capsaicin Topical SolutionAstellas PharmaApproved
43
CGS-200-1 + CGS-200-5 + CGS-200 VehicleAstellas PharmaPhase 2
35
MM-II dose I + MM-II dose II + MM-II dose III + Placebo + Placebo + PlaceboSun PharmaceuticalPhase 2
35
Duloxetine + PlaceboShionogiPhase 3
40
DuloxetineShionogiPhase 3
40
V120083 + Naproxen + PlaceboShionogiPhase 2
35
ONO-4474 + Placebo matching ONO-4474Ono PharmaceuticalPhase 2
27
Duloxetine + PlaceboEli LillyPhase 3
40
Duloxetine (DLX) + Placebo (PLA)Eli LillyPhase 3
40
Duloxetine + placeboEli LillyPhase 3
40